Members of our senior management team hold an average of 25+ years experience in clinical research. Together with PharPoint’s founders, they lead our teams in anticipating challenges, providing quality solutions, and staying ahead of clinical trial deadlines.
Jayme Swinson, MS
Executive Director, Operations
Years of Industry Experience: 20+ years
Expertise includes: Database programming, data standardization, data warehousing
Education: MS in Mathematics, University of North Carolina at Wilmington
Additional Experience: As one of the original members at PharPoint, Mr. Swinson established and led the programming department, defining and refining standard processes across functional areas. He’s supported trials across a range of therapeutic areas from Phase 1 to Phase 4 as well as patient registries.
Amy Flynt, PhD
Executive Director, Biostatistics and Statistical Programming
Years of Industry Experience: 20+ years
Expertise includes: Statistical consulting and oversight, FDA/EMA interaction, IDMCs
Education: PhD in Statistics from North Carolina State University
Additional Experience: Amy Flynt, PhD, joined PharPoint in its inaugural year to grow biostatistics operations. Her experience also includes providing analyses for a patent application, collaborating on the development and validation of a new PRO, and contributing to 8+ publications.
Moya Hawkins
Senior Director, Biometric Strategy
Years of Industry Experience: 20+ years
Expertise includes: Data management; biometric strategy and oversight; EDC; managing/providing oversight for global, multilingual studies
Education: BS from Appalachian State University
Additional Experience: Ms. Hawkins has served on EDC steering committees within several companies, helping organizations decide on and implement new data capture technologies. In addition to her work at PharPoint, she has served on a committee for the Society of Clinical Data Management, a non-profit dedicated to the advancement of clinical data management.
Paul Johnson
Senior Director, Clinical Strategy
Years of Industry Experience: 30+ years in health care
Expertise includes: Project management, risk management, contingency planning, oncology
Education: BS, Biology/Natural Science from Midland University
Additional Experience: Mr. Johnson has participated in numerous studies across a breadth of therapeutic areas. This includes experience managing, providing oversight for, and rescuing oncology studies; experience evaluating antiretroviral therapies; and extensive Phase 1 experience in normal, healthy volunteers in multiple indications.
Stacey Smith Will, CCRA
Senior Director, Clinical Operations
Years of Industry Experience: 25+ years
Expertise includes: Risk mitigation, leadership development, process innovation, clinical site management and monitoring
Education: BA Business Management, North Carolina State University; BA Speech-Communication, North Carolina State University; Certified Clinical Research Associate (CCRA)
Additional Experience: Ms. Will has a highly diverse therapeutic background including autoimmune disorders, infectious disease including COVID, vaccines, rare disease, endocrinology, gastroenterology, & oncology. She is passionate about improving lives through quality delivery of clinical trials.
Dr. Bushra Qureshi, MD, MPH
Senior Medical Advisor
Years of Industry Experience: 7+ years in the pharmaceutical industry
Expertise includes: Medical oversight/monitoring of phase 1 to 4 trials
Education: Doctor of Medicine (MD), Sindh Medical University; Internist (active ML) along with ECFMG certified (USMLE), Master’s in Public Health, Nova Southeastern University
Additional Experience: Dr. Qureshi has a highly diverse therapeutic background including Rare Diseases, Psychiatry, Oncology, Endocrinology, Infectious Diseases, and Neurology.
She is passionate about improving lives through quality delivery of clinical trials and bringing meaningful medicines to patients as quickly and as safely as possible.
Karisa Satterly
Director, Business Development & Marketing
Years of Industry Experience: 10+ years
Expertise includes: Initiatives for growth and diversification of pipeline of work in the clinical research industry
Education: BBA from Texas A&M University
Additional Experience: Prior to PharPoint, Ms. Satterly held various roles of increasing responsibility in the data management industry, including positions in business analytics, marketing, business development, and account management.
Ann Trace, ME
Director, Quality Assurance
Years of Industry Experience: 10+ years
Expertise includes: Regulatory consulting, guidance and compliance support for phase 1 through phase 4, QA and training management and oversight
Education:ME in Biomedical Engineering from the University of Virginia; BS in Physics from Longwood University
Additional Experience: Ms. Trace is a Quality Assurance professional with experience at the sponsor, CRO and investigator site level supporting Phase I through 4 studies. She has managed and led the Quality Assurance and Training programs, participated in FDA regulatory inspections, and has conducted vendor, process, system, clinical investigator site, trial master file, and clinical study report audits. Ms. Trace is a member of the North Carolina Chapter Society of Quality Assurance.